ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 517

Association of Rheumatoid Arthritis Disease Activity and Clinical Profile with Chronic Periodontitis

BEATRIZ RODRIGUEZ-LOZANO1, Jorge Luis Garnier Rodríguez2, Jerián González Febles3, Shashi Dadlani4, Ivan Ferraz-Amaro1, Esmeralda Delgado Frías1, Federico Díaz-González1 and Mariano Sanz Alonso3, 1Rheumatology, Hospital Universitario de Canarias, S/C Tenerife, Spain, 2Odontology, Dental Clinic Garnier, S/C Tenerife, Spain, 3Periodontology, Universidad Complutense de Madrid, Madrid, Spain, 4Periodontology, Dental Clinic Garnier, S/C Tenerife, Spain

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Clinical, Disease Activity, Periodontitis and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster I: Clinical Characteristics/Presentation/Prognosis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Recent clinical data show a clear association between periodontitis (P) and RA. However, there is controversy over whether severity of P is associated with RA activity. Some studies have shown no association or even a negative association and only a study (Mikuls 2014) found a positive association between severity of P and RA activity.  1.To determine whether severity of P affects clinical expression and activity of RA. 2. To define characteristics of P in RA patients with high clinical activity.

Methods: Observational, cross-sectional, case-control study adult RA patients (ACR/EULAR 2010) in a hospital Rheumatology Department,with at least 4 teeth, no dental prophylaxis or antibiotic intake 6 months before. Socio-demographic/ anthropometric variables:smoking status, Graffar scale, annual dental prophylaxis and stress level. RA variables: DAS28 (ESR) DAS28 (CRP),SDAI, RF/ACPA titles, extra-articular manifestations and comorbidities such as osteoporosis (OP), diabetes mellitus (DM), dyslipidemia (DS); glucocorticoids (GC),synthetic and biological therapy (DMARDs/DMARDb). Periodontal variables: plaque index (PI), bleeding on probing (BoP), probing pocket depth (PPD), recession (REC), clinical attachment level (CAL). Dental team: 2 periodontists, 2 general dentists. Full mouth CAL PPD and periapical x-rays were taken. CAL was classified according to the European Workshop 2005 (Tonetti), into level 0 (absence), TL1 (mild), TL2 (severe).Statistical analysis (Stata 13.1) using Student´s t test , Kruskal Wallis and Chi-square test.

Results: We included 187 RA patients, F/M 78.6/21.4%,mean age 54.4 (SD 10.8) y, mean follow-up of 8.8 y, 18.72% had early RA. Positive RF/ACPA:74.9/67.8%. Mean clinical activity: DAS 28 (ESR) 3.81/ DAS 28 (CRP) 3.18/ SDAI 14.49, HAQ 0.76 (0.62). Disease activity: remission 20.86%, low activity 24.06%, moderate activity 45.45%, high activity 9.63%. Treatment: 47.06% received GC (mean daily prednisone 2.85 mg/dl); DMARDs monotherapy/combined 53%/11.76%, DMARDb 30%. Smoking status: current 19,25%/ former 24.6%; low socioeconomic status 36.36% (relative poverty 33.69%); annual dental prophylaxis 43%; dyslipidemia 53.47%, OP 55.86%. Regarding periodontal status,TL2 P in 69. 05% of patients with moderate/high activity vs 30.95% in patients with remission/low activity; 55.34% patients with TL1 P showed RA remission /low activity (p<0.001). A strong association was found between severe P and moderate/high RA activity, with an OR 57.65 + 37.40 (CI 95% 16.16- 205.62). Patients with moderate/high RA activity presented increased values of all periodontal parameters compared to low activity (p<0.005). We observed association between rheumatoid nodes, pleuritis and OP with severe P (p =0.028).  

Conclusion: 1.High-activity RA is associated with severe P. 2. Patients with moderate/high activity RA have higher prevalence of both number and percentage of probing pocket depth ≥ 5mm. 3. Presence of rheumatoid nodes and osteoporosis are related to severe P. 4.These results suggest an independent relationship between severe P and RA with high clinical disease activity regardless of classical factors associated with P.


Disclosure: B. RODRIGUEZ-LOZANO, None; J. L. Garnier Rodríguez, None; J. González Febles, None; S. Dadlani, None; I. Ferraz-Amaro, None; E. Delgado Frías, None; F. Díaz-González, None; M. Sanz Alonso, None.

To cite this abstract in AMA style:

RODRIGUEZ-LOZANO B, Garnier Rodríguez JL, González Febles J, Dadlani S, Ferraz-Amaro I, Delgado Frías E, Díaz-González F, Sanz Alonso M. Association of Rheumatoid Arthritis Disease Activity and Clinical Profile with Chronic Periodontitis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/association-of-rheumatoid-arthritis-disease-activity-and-clinical-profile-with-chronic-periodontitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-rheumatoid-arthritis-disease-activity-and-clinical-profile-with-chronic-periodontitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology